Adenocarcinoma of Lung Clinical Trials
0 recruiting
Showing 1–8 of 8 trials
Recruiting
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
Lung; NodeAdenocarcinoma of Lung
H. Lee Moffitt Cancer Center and Research Institute250 enrolled1 locationNCT05665504
Recruiting
Phase 2
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Adenocarcinoma of Lung
Lantern Pharma Inc.90 enrolled16 locationsNCT05456256
Recruiting
Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Lung CancerAdenocarcinoma of Lung
Masonic Cancer Center, University of Minnesota82 enrolled10 locationsNCT04105270
Recruiting
Phase 1
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
Adenocarcinoma of Lung
Memorial Sloan Kettering Cancer Center25 enrolled7 locationsNCT05764954
Recruiting
Not Applicable
Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery
Lung ResectionAdenocarcinoma of Lung
Azienda USL Reggio Emilia - IRCCS1,000 enrolled1 locationNCT06796816
Recruiting
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Lung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of Lung+1 more
Geneplus-Beijing Co. Ltd.250 enrolled1 locationNCT04566432
Recruiting
Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
Adenocarcinoma of Lung
Tang-Du Hospital2,000 enrolled1 locationNCT06441357
Recruiting
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Lung CancerCancerNSCLC+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1,200 enrolled1 locationNCT05550961